Deadly meningitis on the rise in Russia: Understanding its increasing prevalence
In Russia, the number of meningococcal infections has reached alarming levels, with over 1,200 cases reported in the first half of 2025. This surge represents a significant increase of 260% compared to the same period last year, and the majority of new cases are now found among adults rather than children, reversing previous trends.
The outbreak is primarily linked to migrant workers, many of whom may not have been vaccinated or have limited access to healthcare. The predominant meningococcal serogroups detected include A and W135, which are often associated with severe clinical outcomes. These strains show molecular variations that can affect vaccine efficacy and disease severity.
The shift from children to adults as the primary affected group is concerning, with mortality among adults reaching about 16%, and exceeding 30% in those over 60 years old. In Moscow alone, over 700 adult cases and over 100 children have been reported.
To combat this surge, health officials are urging the introduction of a quadrivalent meningococcal vaccine into the National Vaccination Calendar. They also recommend targeted vaccination of migrants and adults to control the spread, given that outbreaks are concentrated in these groups. Strengthening public health control and surveillance, and raising awareness and access to healthcare for vulnerable populations like migrants are also crucial measures to improve early diagnosis and treatment outcomes.
The socio-economic burden of the surge is significant, with the mortality and severity underlining the urgent need for enhanced preventive strategies. The State Duma committee on healthcare held a meeting on July 15, 2025, dedicated to the spread of meningococcal infection, and calls for mandatory immunization against meningococcus for all children and adolescents are growing louder.
Meningococcal infection, caused by Neisseria meningitidis bacteria, is most commonly spread in closed groups. In its most severe form, it can cause serious brain and organ damage, leading to disability or death. The infection rates grew from 2016 to 2019, and the situation calls for rapid public health responses to stem the outbreak.
References: [1] https://www.gazeta.ru/science/2025/07/16/16783441.shtml [2] https://www.rbc.ru/health/16/07/2025/5ef2681a9a7947e18f8b6a44 [3] https://www.medportal.ru/news/2025/07/16/meningokokkoznye-bolezni-v-rossii-povysili-na-260-v-pervye-polovinye-mesyatsy-2025-godu [4] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7814458/
- The rise in chronic diseases and medical-conditions, such as neurological disorders, highlighted by the alarming increase in meningococcal infections, emphasizes the importance of advancements in science and healthcare, particularly in health-and-wellness and mental-health sectors.
- CBD, a compound derived from cannabis plants, has shown potential in treating neurological disorders, and its benefits in alleviating the symptoms of chronic diseases could provide relief to the growing number of adults affected by meningococcal infections.
- To combat the growing surge of meningococcal infections, health and wellness initiatives should focus on vaccine development and accessibility, paying special attention to vaccines for meningococcal strains like A and W135, known for their associations with severe clinical outcomes.
- In light of the significant socio-economic burden caused by meningococcal infections, there is a need for comprehensive policies that ensure mandatory immunization against meningococcus for all children, adolescents, and at-risk adults, ensuring the improvement of health-and-wellness outcomes and reducing the spread of the illness.
